Total synthesis and biological evaluation of halipeptins A and D and analogues

Journal of the American Chemical Society

Volumn 128, Issue 13, 2006, Pages 4460-4470

  Nicolaou, K C ^c   Lizos, Dimitrios E ^c   Kim, David W ^c   Schlawe, Daniel ^c   De Noronha, Rita G ^c   Longbottom, Deborah A ^c   Rodriquez, Manuela ^a   Bucci, Mariarosaria ^b   Cirino, Giuseppe ^b  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CELLS; CYTOLOGY; ISOMERS; TOXIC MATERIALS; TUMORS;

COLON CANCER CELLS; EPI-ISOLEUCINE; HALIPEPTINS; MACROLACTAMIZATION REACTION;

PROTEINS;

DEPSIPEPTIDE; HALIPEPTIN A; HALIPEPTIN D; OXAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLON CANCER; DRUG ISOLATION; HUMAN; HUMAN CELL; PROTEIN FAMILY; PROTEIN STRUCTURE; SPONGE (PORIFERA); STRUCTURE ANALYSIS; SYNTHESIS;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEPSIPEPTIDES; HUMANS;

EID: 33645474138     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja060064v     Document Type: Article

References (37)

1. Randazzo, R.; Bifulco, G.; Giannini, C.; Bucci, M.; Debitus, C.; Cirino, G.; Gomez-Paloma, L. J. Am. Chem. Soc. 2001, 123, 10870-10876.
2. Della Monica, C.; Randazzo, A.; Bifulco, G.; Cimino, P.; Aquino, M.; Izzo, I.; De Riccardis, F.; Gomez-Paloma, L. Tetrahedron Lett. 2002, 43, 5707-5710.
3. Nicolaou, K. C.; Schlawe, D.; Kim, D.; Longbottom, D. A.; de Noronha, R. G.; Lizos, D. E.; Rao Manam, R.; Faulkner, D. J. Chem.-Eur. J. 2005, 11, 6197-6211.
4. (a) Izzo, I.; Avallone, E.; Della Corte, L.; Maulucci, N.; De Riccardis, F. Tetrahedron: Asymmetry 2004, 15, 1181 -1186 (for some biological data of halipeptin D, see ref 3 in this publication),
5. (b) Data obtained by D. J. Faulkner and which appeared in a summary review, see: Fenical, W.; et al. Pharm. Biol. 2003, 41, 6-14.
6. Nicolaou, K. C.; Kim, D.; Schlawe, D.; Lizos, D. E.; de Noronha, R. G.; Longbottom, D. Angew. Chem., Int. Ed. 2005, 44, 4925-4929.
7. (a) In their total synthesis of halipeptin A, Ma et al. have shown the decanoic acid fragment to be 3(S), 4(S), 7(S): Yu, S.; Pan, X.; Lin, X.; Ma, D. Angew. Chem., Int. Ed. 2005, 44, 135-138.
8. (b) Hara, S.; Makino, K.; Hamada, Y. Tetrahedron Lett. 2006, 47, 1081-1085.
9. (a) Wipf, P.; Miller, C. P.; Venkatraman, S.; Fritch, P. C. Tetrahedron Lett. 1995, 36, 6395-6398.
10. (b) Wipf, P.; Fritch, P. C. Tetrahedron Lett. 1994, 35, 5397-5400.
11. (c) Lafargue, P.; Gucnot, P.; Lellouche, J.-P. Heterocycles 1995, 41, 947-958.
12. (a) Hirotsu, Y.; Shiba, T.; Kaneko, T. Bull. Chem. Soc. Jpn. 1970, 43, 1870-1873.
13. (b) Wipf, P.; Fritch, P. C. Tetrahedron Lett. 1994, 35, 5397-5400.
14. For alternative syntheses of this decanoic acid, see: Della Monica, C.; Maulucci, N.; De Riccardis, F.; Izzo, I. Tetrahedron: Asymmetry 2003, 14, 3371-3378 and ref 6.
15. (R)-4-Bromo-1,2-epoxybutane (17) is commercially available from "Synthon Chiragenics Corporation", 7 Deer Park Drive. Monmouth Junction, NJ 08852.
16. (a) Myers, A. G.; Yang, B. H.; Chen, H.; Gleason, J. L. J. Am. Chem. Soc. 1994, 116, 9361-9362.
17. (b) Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; Gleason, J. L. J. Am. Chem. Soc. 1997, 119, 6496-6511.
18. Kiyooka, S.-I.; Kaneko, Y.; Komura, M.; Matsuo, H.; Nakano, M. J. Org. Chem. 1991, 56, 2276-2278.
19. For other syntheses of this building block, see: (a) Izzo, I.; Avallone, E.; Della Corte, L.; Maulucci, N.; De Riccardis, F. Tetrahedron: Asymmetry 2004, 15, 1181-1186.
20. (b) Hara, S.; Makino, K.; Hamada, Y. Tetrahedron 2004, 60, 8031-8035.
21. For these steps, see: Still, W. C.; Ohmizu, H. J. Org. Chem. 1981, 46, 5242-5244.
22. Formed in situ by reaction of oxalyl chloride with the corresponding acid: (a) Alper, P. B.; Hung, S.-C.; Wong, C.-H. Tetrahedron Lett. 1996, 37, 6029-6032.
23. (b) Lundquist, J. T.; Pelletier, J. C. Org. Lett. 2001, 3, 781-783.
24. (a) Avenoza, A.; Cativiela, C.; Corzana, F.; Peregrina, J. M.; Sucunza, D.; Zurbano, M. M. Tetrahedron: Asymmetry 2001, 12, 949-958.
25. (b) Smith, N. D.; Goodman, M. Org. Lett. 2003, 5, 1035-1038.
26. For previous examples of oxazoline construction through aza-Wittig cyclization, see: (a) Gololobov, Yu. G.; Gusar, N. I.; Chaus, M. P. Tetrahedron 1985, 41, 793-799.
27. (b) Mulzer, J.; Meier, A.; Buschmann, J.; Luger, P. Synthesis 1996, 123-132.
28. (c) Kato, H.; Ohmori, K.; Suzuki, K. Synlett 2001, 1003-1005. For thiazoline formations with triphenylphosphine, see:
29. (d) Kok, G. B.; Campbell, M.; Mackey, B.; von Itzstein, M. J. Chem. Soc., Perkin Trans. 1 1996, 23, 2811-2815.
30. (e) Chen, J.; Forsyth, C. J. Org. Lett. 2003, 5, 1281-1284.
31. (f) Chen, J.; Forsyth, C. J. J. Am. Chem. Soc. 2003, 125, 8734-8735.
32. (a) Nicolaou, K. C.; Estrada, A. A.; Zak, M.; Lee, S. H.; Safina, B. S. Angew. Chem., Int. Ed. 2005, 44, 1378-1382.
33. (b) Furlan, R. L. E.; Mata, E. G.; Mascaretti, O. A. J. Chem. Soc. Perkin Trans. 1 1998, 355-358.
34. (c) Furlan, R. L. E.; Mata, E. G.; Mascaretti, O. A.; Pena, C.; Coba, M. P. Tetrahedron 1998, 54, 13023-13034.
35. (d) Furlan, R. L. E.; Mata, E. G.; Mascaretti, O. A. Tetrahedron Lett. 1996, 37, 5229-5232.
36. Lafargue, P.; Guenot, P.; Lellouche, J.-P. Heterocycles 1995, 41, 947-958.
37. Calhoun, W.; Chang, J.; Carlson, R. P. Agents Actions 1987, 21, 306-309.